Advertisement
Screener

Autolus Therapeutics plc (AUTL) Net Margin

Autolus Therapeutics plc (AUTL) Net Margin

  • 2026-06-30: Net Margin -85.60%.
  • 2026-03-31: Net Margin -273.09%.
  • 2025-12-31: Net Margin -371.90%.
  • 2025-09-30: Net Margin -373.30%.

Complete source-backed net margin history.

Available history
2016-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-85.60%
2026-03-31-273.09%
2025-12-31-371.90%
2025-09-30-373.30%
2025-06-30-229.02%
2025-03-31-781.13%
2024-12-31-95193.10%
2024-03-31-522.15%
2021-03-31-12366.54%
2020-06-30-10936.86%
2020-03-31-8838.17%
2019-12-31-13250.49%
2019-09-30-9174.41%
2019-06-30-8425.44%
2019-03-31-1383.86%
2018-12-31-6975.68%
2018-09-30-4188.93%
2018-06-30-1726.86%
2017-12-31-3257.14%

Annual Net Margin

DateNet Margin
2025-12-31-381.40%
2024-12-31-2180.45%
2023-12-31-12272.26%
2019-12-31-4258.91%
2018-09-30-3180.60%
2017-09-30-1165.21%
2016-09-30-1035.48%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56